Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, H. S.
Right arrow Articles by Lee, M.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, H. S.
Right arrow Articles by Lee, M.-S.
[Cancer Research 65, 6111-6119, July 15, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Caspase-Mediated p65 Cleavage Promotes TRAIL-Induced Apoptosis

Hun Sik Kim1, Inik Chang1, Ja Young Kim1, Kyung-Hee Choi2 and Myung-Shik Lee1

1 Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine and 2 Department of Biology, College of Natural Sciences, Chung-Ang University, Seoul, Korea

Requests for reprints: Myung-Shik Lee, Department of Medicine, Samsung Medical Center, 50 Irwon-dong Kangnam-ku, Seoul 135-710, Korea. Phone: 82-2-3410-3436; Fax: 82-2-3410-0388; E-mail: mslee{at}smc.samsung.co.kr.

Tumor necrosis factor (TNF)–related apoptosis-inducing ligand (TRAIL) is cytotoxic to a wide variety of transformed cells, but not to most normal cells, implying potential therapeutic value against advanced cancer. However, signal transduction in TRAIL-mediated apoptosis is not clearly understood compared with other TNF family members. Specifically, it is not yet understood how TRAIL controls nuclear factor {kappa}B (NF-{kappa}B) activation and overcomes its antiapoptotic effect. We explored the regulation of NF-{kappa}B activity by TRAIL and its role in apoptosis. TRAIL combined with I{kappa}B{alpha}-"superrepressor" induced potent apoptosis of SK-Hep1 hepatoma cells at low concentrations of TRAIL that do not independently induce apoptosis. Apoptosis by high concentrations of TRAIL was not affected by I{kappa}B{alpha}-superrepressor. Although TRAIL alone did not induce NF-{kappa}B activity, TRAIL combined with z-VAD significantly increased NF-{kappa}B activation. Analysis of the NF-{kappa}B activation pathway indicated that TRAIL unexpectedly induced cleavage of p65 at Asp97, which was blocked by z-VAD, accounting for all of these findings. p65 expression abrogated apoptosis and increased NF-{kappa}B activity in TRAIL-treated cells. Cleavage-resistant p65D97A further increased NF-{kappa}B activity in TRAIL-treated cells, whereas the COOH-terminal p65 fragment acted as a dominant-negative inhibitor. XIAP levels were increased by TRAIL in combination with z-VAD, whereas XIAP levels were decreased by TRAIL alone. Cleavage of p65 was also detected after FRO thyroid cancer cells were treated with TRAIL. These results suggest that TRAIL induces NF-{kappa}B activation, but simultaneously abrogates NF-{kappa}B activation by cleaving p65, and thereby inhibits the induction of antiapoptotic proteins such as XIAP, which contributes to the strong apoptotic activity of TRAIL compared with other TNF family members.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Kim, I. Millet, H. S. Kim, J. Y. Kim, M. S. Han, M.-K. Lee, K.-W. Kim, R. S. Sherwin, M. Karin, and M.-S. Lee
NF-{kappa}B prevents beta cell death and autoimmune diabetes in NOD mice
PNAS, February 6, 2007; 104(6): 1913 - 1918.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Kanan, G. Moiseyev, N. Agarwal, J.-X. Ma, and M. R. Al-Ubaidi
Light Induces Programmed Cell Death by Activating Multiple Independent Proteases in a Cone Photoreceptor Cell Line
Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 40 - 51.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.